Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate loading dose in diabetic ketoacidosis
IRCT20220928056051N3Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of magnesium sulfate in diabetic ketoacidosis (DKA) (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: Total prescribed insulin dose, Total prescribed potassium dose and 2 more. Started May 2023; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
diabetic ketoacidosis (DKA)
Beyond the preview
Go deeper on IRCT20220928056051N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220928056051N3.